• Patients who are over 18 years of age • Both male and female • Any patient positive for SARS 2-Corona Virus by RT-PCR tests or antigen testing using nasopharyngeal swab/aspirate within 48 hours prior to randomization and is admitted for treatment to NIID. • Cycle threshold (Ct) value <38 at the time of recruitment • Mild to moderate COVID-19 infection ­ Mild disease: Symptoms such as fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, anosmia. ­ Moderate disease: Symptoms of mild disease and Signs such as shortness of breath with exertion, respiratory rate >= 20 but <30/min, saturation of oxygen >93% of room air , heart rate >= 90/min but <125/min • Negative antibody test • Within 4 days of onset of symptoms and RT-PCR positivity within 48 hours in a symptomatic patient

• Patients who are over 18 years of age • Both male and female • Any patient positive for SARS 2-Corona Virus by RT-PCR tests or antigen testing using nasopharyngeal swab/aspirate within 48 hours prior to randomization and is admitted for treatment to NIID. • Cycle threshold (Ct) value <38 at the time of recruitment • Mild to moderate COVID-19 infection ­ Mild disease: Symptoms such as fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, anosmia. ­ Moderate disease: Symptoms of mild disease and Signs such as shortness of breath with exertion, respiratory rate >= 20 but <30/min, saturation of oxygen >93% of room air , heart rate >= 90/min but <125/min • Negative antibody test • Within 4 days of onset of symptoms and RT-PCR positivity within 48 hours in a symptomatic patient